Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

1.

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF; PREEMPT 2 Chronic Migraine Study Group.

Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17.

PMID:
20647171
[PubMed - indexed for MEDLINE]
Free Article
2.

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group.

Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17.

PMID:
20647170
[PubMed - indexed for MEDLINE]
Free Article
3.

OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.

Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC.

Headache. 2011 Oct;51(9):1358-73. doi: 10.1111/j.1526-4610.2011.01990.x. Epub 2011 Aug 29.

PMID:
21883197
[PubMed - indexed for MEDLINE]
4.

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.

Lipton RB, Varon SF, Grosberg B, McAllister PJ, Freitag F, Aurora SK, Dodick DW, Silberstein SD, Diener HC, DeGryse RE, Nolan ME, Turkel CC.

Neurology. 2011 Oct 11;77(15):1465-72. doi: 10.1212/WNL.0b013e318232ab65. Epub 2011 Sep 28.

PMID:
21956721
[PubMed - indexed for MEDLINE]
5.

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT Chronic Migraine Study Group.

Headache. 2010 Jun;50(6):921-36. doi: 10.1111/j.1526-4610.2010.01678.x. Epub 2010 May 7.

PMID:
20487038
[PubMed - indexed for MEDLINE]
6.

OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.

Frampton JE.

Drugs. 2012 Apr 16;72(6):825-45. doi: 10.2165/11208880-000000000-00000. Review.

PMID:
22468643
[PubMed - indexed for MEDLINE]
7.

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.

Aurora SK, Dodick DW, Diener HC, DeGryse RE, Turkel CC, Lipton RB, Silberstein SD.

Acta Neurol Scand. 2014 Jan;129(1):61-70. doi: 10.1111/ane.12171. Epub 2013 Sep 20.

PMID:
24107267
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.

Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener HC, Aurora SK, Sirimanne M, DeGryse RE, Turkel CC, Dodick DW.

J Neurol Sci. 2013 Aug 15;331(1-2):48-56. doi: 10.1016/j.jns.2013.05.003. Epub 2013 Jun 19.

PMID:
23790235
[PubMed - indexed for MEDLINE]
9.

Botox for chronic migraine.

[No authors listed]

Drug Ther Bull. 2011 Feb;49(2):22-4; quiz iii-iv. doi: 10.1136/dtb.2010.10.0008. Review.

PMID:
21304165
[PubMed - indexed for MEDLINE]
10.

OnabotulinumtoxinA for the treatment of chronic migraine not quite there. . .

Torgovnick J.

Cephalalgia. 2011 Feb;31(3):377; author reply 378-9. doi: 10.1177/0333102410388529. Epub 2010 Nov 22. No abstract available.

PMID:
21098110
[PubMed - indexed for MEDLINE]
11.

OnabotulinumtoxinA (BOTOX®): a guide to its use in preventing headaches in adults with chronic migraine.

Lyseng-Williamson KA, Frampton JE.

CNS Drugs. 2012 Aug 1;26(8):717-23. doi: 10.2165/11208930-000000000-00000.

PMID:
22784019
[PubMed - indexed for MEDLINE]
12.

Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.

Chankrachang S, Arayawichanont A, Poungvarin N, Nidhinandana S, Boonkongchuen P, Towanabut S, Sithinamsuwan P, Kongsaengdao S.

Headache. 2011 Jan;51(1):52-63. doi: 10.1111/j.1526-4610.2010.01807.x. Epub 2010 Nov 16.

PMID:
21083558
[PubMed - indexed for MEDLINE]
13.

[Botulinum toxin type A for preventive treatment of chronic migraines].

Göbel H, Heinze A.

HNO. 2012 Jun;60(6):490-5. doi: 10.1007/s00106-012-2496-z. German.

PMID:
22669437
[PubMed - indexed for MEDLINE]
14.

[Botulinum toxin type A in the prophylactic treatment of chronic migraine].

Göbel H, Heinze A.

Schmerz. 2011 Sep;25(5):563-70; quiz 571. doi: 10.1007/s00482-011-1084-6. German.

PMID:
21938606
[PubMed - indexed for MEDLINE]
15.

Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.

Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.

Pharmacotherapy. 2009 Jul;29(7):784-91. doi: 10.1592/phco.29.7.784.

PMID:
19558252
[PubMed - indexed for MEDLINE]
16.

Botulinum toxin type A and acute drug costs in migraine with triptan overuse.

Christie SN, Giammarco R, Gawel M, Mackie G, Gladstone J, Becker WJ.

Can J Neurol Sci. 2010 Sep;37(5):588-94.

PMID:
21059503
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial.

Dmochowski R, Chapple C, Nitti VW, Chancellor M, Everaert K, Thompson C, Daniell G, Zhou J, Haag-Molkenteller C.

J Urol. 2010 Dec;184(6):2416-22. doi: 10.1016/j.juro.2010.08.021. Epub 2010 Oct 16.

PMID:
20952013
[PubMed - indexed for MEDLINE]
18.

A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.

Relja M, Poole AC, Schoenen J, Pascual J, Lei X, Thompson C; European BoNTA Headache Study Group.

Cephalalgia. 2007 Jun;27(6):492-503. Epub 2007 Apr 11.

PMID:
17428299
[PubMed - indexed for MEDLINE]
19.

OnabotulinumtoxinA for chronic migraine.

Blumenfeld A, Evans RW.

Headache. 2012 Jan;52(1):142-8. doi: 10.1111/j.1526-4610.2011.02081.x. No abstract available.

PMID:
22268776
[PubMed - indexed for MEDLINE]
20.

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.

Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD; BOTOX CDH Study Group.

Headache. 2005 Apr;45(4):315-24.

PMID:
15836567
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk